Latest Articles
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Welcoming First Child Together - AOL.com
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Welcoming First Child Together AOL.com
Published: May 15, 2026, 2:44 p.m.
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Daughter's Birth, Insider Says They're "Working on Things" - Yahoo News Singapore
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Daughter's Birth, Insider Says They're "Working on Things" Yahoo News Singapore
Published: May 15, 2026, 2:44 p.m.
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor - Femtech Insider
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor Femtech Insider
Published: May 15, 2026, 11:33 a.m.
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer - Minichart
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer Minichart
Published: May 14, 2026, 4:30 p.m.
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis - Newswise
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis Newswise
Published: May 14, 2026, 12:40 p.m.
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M - TradingView
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M TradingView
Published: May 14, 2026, 11:33 a.m.
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - PR Newswire
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment PR Newswire
Published: May 14, 2026, 11:30 a.m.
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - Moomoo
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Moomoo
Published: May 14, 2026, 11:30 a.m.
Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts - The Manila Times
Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts The Manila Times
Published: May 13, 2026, 8:14 p.m.
PL Pledges Women’s Health Clinic And Treatments For Reproductive Conditions - Lovin Malta
PL Pledges Women’s Health Clinic And Treatments For Reproductive Conditions Lovin Malta
Published: May 13, 2026, 7:36 p.m.
Link copied to clipboard!